Nasacort Aq

   
Google
 
Web NewDrugInformation.com

Nasacort Aq


Drug - Nasacort Aq
The trade name of the product as shown on the labeling.

Dosage - SPRAY, METERED; NASAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Triamcinolone Acetonide
Multiple ingredients are in alphabetical order.

Strength - 0.055MG/SPRAY
The potency of the active ingredient(s), Triamcinolone Acetonide. May repeat for multiple part products.

Applicant - AVENTIS
The firm name holding legal responsibility for Nasacort Aq. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020468
The FDA assigned number to Nasacort Aq. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Nasacort Aq. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 20, 1996
The date Nasacort Aq was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Nasacort Aq. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Nasacort Aq is in. Format is RX, OTC, DISCN.

Applicant Full Name - Aventis Pharmaceutical Products Inc
The full name of the firm holding legal responsibility for the new application of Nasacort Aq.

Nasacort Aq